Lesaffre acquires Recombia Biosciences, a biotechnology company specialized in high-throughput genome editing and synthetic biology

Procelys is the business unit of Lesaffre dedicated to biotechnology industries. Procelys provides biotechnology companies with a line of fermentation nutrients developed to improve the bacterial growth and productivity of microorganisms and animal cells. These efficient cellular nutrients, yeast extracts, dried yeast, autolyzed yeast and yeast peptones are specifically designed for the production of new molecules to benefit human and animal species, such as medicinal products, biological diagnostic tests, food and feed bio-ingredients, biopesticides and more. This know-how is applied in an environmentally-friendly manner. In addition, Procelys makes direct contributions to improving the lives, health and wellness of our planet’s living creatures.